AAWHOTCMedicinal Chemicals & Botanical ProductsFiscal year ends December 31

Ascend Wellness Holdings, Inc.

Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 12, 2026

$0.39−0.00 (-0.73%)

Close on Oct 19, 2026

Market cap: $79.60M
P/E (TTM): –
Dividend yield: –

Ascend Wellness Holdings, Inc. income statement

Annual Quarterly TTM

Millions of USD, except per-share data. Shares in millions.

Line item	FY 2025 2025-12-31	FY 2024 2024-12-31	FY 2023 2023-12-31	FY 2022 2022-12-31	FY 2021 2021-12-31	FY 2020 2020-12-31	FY 2019 2019-12-31
Revenue	501	562	519	406	332	144	12
Cost of Revenue	331	377	363	271	196	83	8.74
Gross Profit	170	184	155	135	136	61	3.29
General & Administrative	170	179	159	137	117	53	29
Operating Expenses	187	179	159	142	153	53	29
Operating Income	-17	4.73	-3.62	-7.53	-17	7.85	-26
Interest Expense	51	45	37	32	64	13	6.48
Other Non-Operating Income	-50	-45	-11	-32	-64	-13	-6.45
Asset Impairment Charges	0	0	0	0	0	0	0
Gain (Loss) on Sale of Assets	-0.06	-0.02	0.23	-0.35	-0.61	-0.29	0
Legal Settlements	-17	0	0	-5.00	-37	0	0
Pretax Income	-67	-40	-15	-39	-81	-5.14	-33
Income Tax Expense	51	45	33	42	42	19	0.67
Net Income incl. Noncontrolling Interests	-118	-85	-48	-81	-123	-24	-33
Minority Interest in Earnings	–	–	–	0	0	1.60	-1.35
Net Income	–	–	–	-81	-123	-25	-32
EPS (Basic)(per share)	-0.58	-0.40	-0.24	-0.44	-0.82	-0.27	-0.37
EPS (Diluted)(per share)	-0.58	-0.40	-0.24	-0.44	-0.82	-0.27	-0.37
Shares Outstanding (Basic, Weighted)(shares)	203	212	199	183	149	95	87
Shares Outstanding (Diluted, Weighted)(shares)	203	212	199	183	149	95	87
EBITDA	57	71	55	30	5.02	20	-22
Provision for Credit Losses	0	0	0	0	0	0	0

Italic numbers are calculated by StockData (for example Q4 = full year − nine months). Per-share data and share counts are adjusted for stock splits. Hover a number for its source; click it to open the filing on SEC.gov. Click a row to chart it.

Ratios

Latest available, balances at Jun 30, 2026

Profitability, TTM

Gross margin: 36.7%
Operating margin: -2.2%
Net margin: –
Return on equity, FY2025: –

Financial strength

Current ratio: 1.66
Debt to equity: -3.71
Debt to assets: 35.9%
Cash to current liabilities: 59.5%

Valuation

P/E ratio: –
Price to sales: 0.16
Price to book: –
Dividend yield: –